Effects of local delivery of trapidil on neointima formation in a rabbit angioplasty model

British Journal of Pharmacology

Volumn 129, Issue 3, 2000, Pages 566-572

  Zacharowski, Kai ^a   Schneidmüller, Dorien ^b   Ibe, Waltraut ^b   Großer, Tilo ^b   Buerke, Michael ^b   Meyer, Jürgen ^b   Darius, Harald ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Angioplasty; Apoptosis; Femoral artery; Histo (patho) logy; Infusion balloon catheter; Neointima formation; New Zealand White rabbit; Smooth muscle cells; Trapidil

Indexed keywords

CORONARY VASODILATING AGENT; TRAPIDIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMORAL ARTERY; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT;

EID: 0033967162     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703098     Document Type: Article

References (37)

1. Austin, G.E., Ratliff, N.B., Hollman, J., Tabei, S. & Phillips, D.F. (1985). Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol., 6, 369-375.
2. Birnbaum, Y., Fishbein, M.C., Luo, H., Nishioka, T. & Siegel, R.J. (1997). Regional remodeling of atherosclerotic arteries: a major determinant of clinical manifestations of disease. J. Am. Coll. Cardiol., 30, 1149-1164.
3. Bonisch, D., Weber, A.A., Wittpoth, M., Osinski, M. & Schrör, K. (1998). Antimitogenic effects of trapidil in coronary artery smooth muscle cells by direct activation of protein kinase A. Mol. Pharmacol., 54, 241-248.
4. Califf, R.M., Fortin, D.F., Frid, D.J., Harlan, W.R.D., Ohman, E.M., Bengtson, J.R., Nelson, C.L., Tcheng, J.E., Mark, D.B. & Stack, R.S. (1991). Restenosis after coronary angioplasty: an overview. J. Am. Coll. Cardiol., 17, 2B-13B.
5. Casscells, W. (1992). Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation, 86, 723-729.
6. Darius, H., Buerke, M., Boissel, J.P., Grosser, T., Veit, K., Zacharowski, K. & Meyer, J. (1997). Local drug delivery and gene therapy. Herz. 22, 347-354.
7. Dartsch, P.C., Bauriedel, G., Schinko, I., Weiss, H.D., Hofling, B. & Betz, E. (1989). Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy. Atherosclerosis, 80, 149-157.
8. Davis, R.J. (1993). The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem., 268, 14553-14556.
9. Farb, A., Virmani, R., Atkinson, J.B. & Kolodgie, F.D. (1990). Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty. J. Am. Coll. Cardiol., 16, 1421-1429.
10. Fischell, T.A. (1990). Coronary artery spasm after percutaneous transluminal coronary angioplasty: pathophysiology and clinical consequences. Cathet. Cardiovasc. Diagn., 19, 1-3.
11. Gorman, A., McCarthy, J., Finucane, D., Reville, W. & Cotter, T.G. (1996). In Cotter, T.G. & Martin, S.J. eds. Techniques in apoptosis, a user's guide. London: Portland Press Ltd.
12. Gratzner, H.G. (1982). Monoclonal antibody to 5-bromo-and 5-iododeoxyuridine: A new reagent for detection of DNA replication. Science, 218, 474-475.
13. Gravanis, M.B. & Roubin, G.S. (1989). Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis. Hum. Pathol., 20, 477-485.
14. Grosser, T., Buerke, M., Kuhlmeier, K., Zacharowski, K., Ibe, W., Meyer, J. & Darius, H. (1998). Local delivery of the NO-donor linsidomine reduces neointima formation following balloon injury. FASEB J., 12, 2771.
15. Harker, L.A. (1987). Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am. J. Cardiol., 60, 20B-28B.
16. Ibe, W., Buerke, M., Grosser, T., Boissel, J.P., Meyer, J. & Darius, H. (1997). NO-donors stimulate apoptosis in vascular smooth muscle cells in vitro, Naunyn-Schmiedebergs Arch. Pharmacol., 355, 152.
17. Jarmolych, J., Daoud, A.S., Landau, J., Fritz, K.E. & McElvene, E. (1968). Aortic media explants. Cell proliferation and production of mucopolysaccharides, collagen, and elastic tissue. Exp. Mol. Phathol., 9, 171-188.
18. Kockx, M.M., Muhring, J., Knaapen, M.W. & De Meyer, G.R.Y. (1998). RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. Am. J. Pathol., 152, 885-888.
19. Leimgruber, P.P., Roubin, G.S., Hollman, J., Cotsonis, G.A., Meier, B., Douglas, J.S., King, Jr, S.B. & Gruentzig, A.R. (1986). Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation, 73, 710-717.
20. Libby, P., Schwartz, D., Brogi, E., Tanaka, H. & Clinton, S.K. (1992). A cascade model for restenosis. A special case of atherosclerosis progression. Circulation, 86, III47-III52.
21. Liu, M.W., Roubin, G.S., Robinson, K.A., Black, A.J., Hearn, J.A., Siegel, R.J. & King, S.B.D (1990). Trapidil in preventing restenosis after balloon angioplasty in the atherosclerotic rabbit. Circulation, 81, 1089-1093.
22. Maresta, A., Balducelli, M., Cantini, L., Casari, A., Chioin, R., Fabbri, M., Fontanelli, A., Monici Preti, P.A., Repetto, S., De Servi, S. & Varant, E., for the STARC investigators. (1994). Trapidil (triazolipyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica. Circulation, 90, 2710-2715.
23. Mazur, W., Ali, N.M., Raizner, A.E. & French, B.A. (1994). Coronary restenosis and gene therapy. Tex. Heart Inst. J., 21, 104-111.
24. McBride, W., Lange, R.A. & Hillis, L.D. (1988). Restenosis after successful coronary angioplasty. Pathophysiology and prevention. N. Engl. J. Med., 318, 1734-1737.
25. Morishita, R., Gibbons, G.H., Ellison, K.E., Nakajima, M., Zhang, L., Kaneda, Y., Ogihara, T. & Dzau, V.J. (1993). Single intraluminal delivery of antisensc cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc. Natl. Acad. Sci. U.S.A., 90, 8474-8478.
26. Mozdzen, Jr, J.J. & Keren, D.F. (1982). Detection of immunoglobulin A by immunofluorescence in glycol methacrylate-embedded human colon. J. Histochem. Cytochem., 30, 532-535.
27. Ohnishi, H., Yamaguchi, K., Shimada, S., Suzuki, Y. & Kumagai, A. (1981). A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor. Life Sci., 28, 1641-1646.
28. Okamoto, S., Inden, M., Setsuda, M., Konishi, T. & Nakano, T. (1992). Effects of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, in preventing restenosis after percutaneous transluminal coronary angioplasty. Am. Heart J., 123, 1439-1444.
29. Perlman, H., Maillard, L., Krasinski, K. & Walsh, K. (1997). Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation, 95, 981-987.
30. Post, M.J., Borst, C. & Kuntz, R.E. (1994). The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation, 89, 2816-2821.
31. Schini-Kerth, V.B., Fisslthaler, B., Van Obberghen-Schilling, E. & Busse, R. (1996). Serotonin stimulates the expression of thrombin receptors in cultured vascular smooth muscle cells. Role of protein kinase C and protein tyrosine kinases. Circulation, 93, 2170-2177.
32. Scott-Burden, T. & Vanhoutte, P.M. (1993). The endothelium as a regulator of vascular smooth muscle proliferation. Circulation, 87, 51-55.
33. Scott-Burden, T. & Vanhoutte, P.M. (1994). Regulation of smooth muscle cell growth by endothelium-derived factors. Tex. Heart Inst. J., 21, 91-97.
34. Tiell, M.L., Sussman, II, Gordon, P.B. & Saunders, R.N. (1983). Suppression of fibroblast proliferation in vitro and of myointimal hyperplasia in vivo by the triazolopyrimidine, Trapidil. Artery, 12, 33-50.
35. Vanderlaan, M. & Thomas, C.B. (1985). Characterization of monoclonal antibodies to bromodeoxyuridine. Cytometry, 6, 501-555.
36. Zucker, T.P., Grosser, T., Morinelli, T., Halushka, P.V., Sachinidis, A., Vetter, H. & Schrör, K. (1995). Potentiation of PDGF-induced growth responses in coronary artery smooth muscle cells by thromboxane. Agents Actions Suppl., 45, 53-58.
37. Zawaka, P., Tannhauser, R. & Schrör. K. (1998). Trapidil reduces nuclear factor kappa B activation in reperfused ischmic rabbit hearts and decreases ischemic myocardial injury. Naunyn-Schmiedebergs Arch. Pharmacol., 357, 396.